| Similar Articles |
|---|
 |
The Motley Fool
January 26, 2004
Alyce Lomax |
Amerisource's Fightin' Words Wholesale drug distributor AmerisourceBergen's first-quarter profits rise, but will a fight with veterans end peacefully?   |
The Motley Fool
April 26, 2004
Alyce Lomax |
Amerisource Hangs On While pharmaceutical distribution is an industry with obvious opportunities for financial reward, the potential for a price war remains a risk. |
The Motley Fool
July 1, 2004
W.D. Crotty |
Drug Wholesalers Taking a Beating A sharp drop at drug wholesaler Cardinal Health provides a unique buying opportunity. |
The Motley Fool
October 25, 2004
Tom Taulli |
McKesson Gets Pain Relief Drug distributors would like to forget 2004. But this may mean bargains for investors. |
The Motley Fool
January 30, 2006
Brian Gorman |
Cardinal Inches Higher The distribution is looking healthier, but Cardinal Health still has work to do. Investors, take note. |
The Motley Fool
December 10, 2004
Brian Gorman |
Cardinal Picks a Lilly Cardinal Health's deal with Lilly suggests the new fee-for-service model is gaining traction. |
The Motley Fool
October 8, 2007
Billy Fisher |
McKesson Expands Its Empire A new acquisition strengthens the company's presence in the cancer drug market. Investors, take note. |
The Motley Fool
October 26, 2005
Stephen D. Simpson |
Cardinal's Tweet More Sweet Changes at the giant manufacturer, distributor, and service provider in the health-care industry are working out well, but the stock price already reflects it. |
The Motley Fool
October 28, 2004
Brian Gorman |
Cardinal's Good News: No News The drug wholesaler took a major step toward rehabilitating itself with the release of its 10-K. |
The Motley Fool
May 6, 2008
Steven Renaldi |
McKesson Garners Generic Growth New products offer the generic-drug distributor profit potential in a competitive industry. |
The Motley Fool
November 7, 2007
Billy Fisher |
Cardinal Has Its Wings Clipped Despite a healthy year-over-year pop of 15% in EPS from operations, much of the focus in the first-quarter was shifted to a weak performance by Cardinal's pharmaceutical services segment. |
The Motley Fool
May 20, 2004
Tom Taulli |
Cardinal Rules of M&A Cardinal Health is upbeat on its latest acquisition, but needs bigger deals to push growth. |
The Motley Fool
May 6, 2005
W.D. Crotty |
McKesson's New Pep Pill The drug wholesaler reports strong fourth-quarter results as it moves to a fee-for-service model. |
The Motley Fool
January 26, 2007
Billy Fisher |
A Clean Bill of Health at Cardinal Good results and a key divestiture have this health care company rolling. Investors, take note. |
The Motley Fool
June 28, 2005
Brian Gorman |
Cardinal Changes Course The health care company's warning is a disappointment, but the firm's new focus on returning cash to shareholders is far from bad news. |
BusinessWeek
August 30, 2004
Gene G. Marcial |
PSS Is Really Delivering The Goods When David Smith took the CEO job at PSS World Medical in 2000, sales stood at $160 million. They've since rocketed to $1.35 billion. No wonder industry giants are eyeballing the company: They hope Smith will sell. |
The Motley Fool
November 9, 2005
W.D. Crotty |
McKesson Fattens Its Margins The pharma distributor turns in an outstanding second quarter. Because McKesson is a broadly based supplier, it avoids the roller-coaster impact that specific drug successes and failures have on drug-developer stocks. |
The Motley Fool
August 5, 2005
Stephen D. Simpson |
Can This Cardinal Sing? If Cardinal Health succeeds in its plans to return more capital to shareholders, this could become an interesting income play. This stock is worth keeping an eye on for the future. |
The Motley Fool
July 28, 2004
Brian Gorman |
Cardinal Watching Cardinal Health continues to be pummeled, but wait patiently, because a buying opportunity could emerge. |
The Motley Fool
January 21, 2005
Rich Duprey |
Cardinal Back in the Nest Drug distributor and Japanese pharma Eisai come to agreement after all. |
The Motley Fool
December 22, 2010
Seth Jayson |
Here's How McKesson Is Making So Much for You With TTM margins all at a five-year high, McKesson looks like it's doing great. |
BusinessWeek
November 24, 2003
Roger O. Crockett |
Cardinal Health, Heal Thyself CEO Walter aims to revive growth, selling high-tech gear and expanding overseas. |
The Motley Fool
June 13, 2006
Ryan Fuhrmann |
Cardinal Looks to Deliver Cardinal Health has been through a tumultuous couple of years but appears to have weathered company-specific and industry storms. If the drug distributor can meet its long-term goals, then its stock should represent a long-term solid investment. |
The Motley Fool
February 1, 2006
Rich Duprey |
Candela Is Finally White Hot The aesthetic laser maker finally produces the white-hot sales growth it promised -- two years ago. In midday trading, the stock soared 30%. |
The Motley Fool
August 3, 2006
Ryan Fuhrmann |
Cardinal Distributes the Goods The drug wholesaler and distributor has to regain investor confidence and rebuild a track record in a changed industry. So far, so good for 2006. Let's see if any further information can be found once Cardinal submits its 10-K filing to the SEC. |
The Motley Fool
May 2, 2008
Steven Renaldi |
Cardinal Health Gets Its Nest in Order Share price rises as investors hope the company is beginning to put some of its troubles behind it. |
The Motley Fool
April 7, 2011
Brandon Glenn |
"Generic Wave" to Drive Cardinal Health's Profitability in Coming Years The generic wave could mean big money for Cardinal and top competitors. |
The Motley Fool
October 28, 2011
Anders Bylund |
Computer Programs & Systems' Shares Got Crushed: What You Need to Know Is this meaningful? Or just another movement for Computer Programs & Systems? |
The Motley Fool
October 12, 2004
W.D. Crotty |
A Bargain in Drug Distribution? D&K Healthcare Resources' stock surprises investors, but the drop brings a favorable valuation. |
The Motley Fool
February 13, 2004
W.D. Crotty |
McKesson Still Wants Moore Buying the stock of a takeover candidate has its risks. The acquision of surgical and pharmaceutical products specialist Moore Medical by SJ Strategic Investments fell through, but McKesson is still interested. There are still many possibilities for Disney. |
The Motley Fool
December 13, 2010
Seth Jayson |
Are McKesson's Earnings Better Than they Look? With questionable cash flows amounting to only 2.1% of operating cash flow, McKesson's cash flows look clean. |
BusinessWeek
August 7, 2006
Arlene Weintraub |
McKesson's Booster Shot McKesson Corp. holds the unenviable distinction of being one of the world's biggest yet least profitable companies. The problem: huge sales, tiny profits. High-margin tech products could help. |
The Motley Fool
August 24, 2011
Brandon Glenn |
Cardinal Health Sees Opportunity (but Faces Challenges) in Specialty Drugs Is Cardinal up for the challenge? |
The Motley Fool
September 30, 2008
Brian Orelli |
Cardinal Health Clips Its Wings Does it make sense for the drug wholesaler to spin off its medical equipment business? |
